August 01, 2014 8:43 PM ET

Biotechnology

Company Overview of ZaBeCor Pharmaceuticals, LLC

Company Overview

ZaBeCor Pharmaceuticals, LLC, a clinical stage biotechnology company, focuses on the development of siRNA, antisense, and other molecular technologies for the treatment of asthma, allergy, and other inflammatory and infectious diseases. Its products include Excellair, an anti-inflammatory treatment of asthma, allergy, ARDS, COPD, avian flu inflammation, uveitis, cystitis, rheumatoid arthritis, and other autoimmune and inflammatory diseases; Recruitin Phagocytosis for infection based on gene therapy; Disarmin Phagocytosis for autoimmune diseases based on gene therapy; and Hematrol Steroid for low blood platelets, anemia (hemolytic), rheumatoid arthritis, systemic lupus, ulcerative colitis, Cr...

Two Bala Plaza

Suite 300

Bala Cynwyd, PA 19004

United States

Founded in 1992

Phone:

610-660-7733

Fax:

215-438-5123

Key Executives for ZaBeCor Pharmaceuticals, LLC

Founder
Age: 70
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
VaxInnate, Inc. United States
Verex Laboratories, Inc. United States
VLST Corporation United States
Phyllom LLC United States
Capital Genomix, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ZaBeCor Pharmaceuticals, LLC, please visit www.zabecor.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.